A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGY

  • R. JOSEPH BABAIAN
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • ANTS TOI
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • KAZUMI KAMOI
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • PATRICIA TRONCOSO
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • JOAN SWEET
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • ROBERT EVANS
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • DENNIS JOHNSTON
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
  • MICHAEL CHEN
    From the Departments of Urology, Pathology and Biomathetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and the Departments of Medical Imaging and Pathology, Toronto General Hospital and Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

収録刊行物

  • Journal of Urology

    Journal of Urology 163 (1), 152-157, 2000-01

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (18)*注記

もっと見る

キーワード

問題の指摘

ページトップへ